| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.09B | 17.45B | 15.92B | 13.47B | 15.67B | 14.62B |
| Gross Profit | 6.96B | 7.61B | 6.88B | 5.48B | 6.15B | 6.06B |
| EBITDA | 5.00B | 5.64B | 4.94B | 3.59B | 4.58B | 4.71B |
| Net Income | 2.06B | 2.99B | 3.25B | 1.90B | 3.07B | 2.96B |
Balance Sheet | ||||||
| Total Assets | 24.32B | 28.32B | 28.68B | 24.97B | 24.29B | 22.54B |
| Cash, Cash Equivalents and Short-Term Investments | 6.62B | 8.92B | 11.13B | 10.86B | 10.36B | 10.95B |
| Total Debt | 1.91B | 3.97B | 2.31B | 2.95B | 3.60B | 4.35B |
| Total Liabilities | 4.05B | 4.88B | 5.25B | 4.91B | 5.99B | 7.39B |
| Stockholders Equity | 20.26B | 23.44B | 23.43B | 20.06B | 18.30B | 15.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.56B | 2.40B | 2.18B | 1.89B | 2.45B |
| Operating Cash Flow | 0.00 | 3.34B | 3.84B | 3.58B | 2.76B | 3.03B |
| Investing Cash Flow | 0.00 | -1.20B | -3.12B | -1.03B | -1.95B | -406.07M |
| Financing Cash Flow | 0.00 | -3.65B | -1.64B | -1.58B | -2.59B | 4.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥94.15B | 13.80 | ― | 1.68% | 2.72% | 33.10% | |
75 Outperform | ¥109.84B | 16.20 | ― | 0.76% | 6.64% | 18.46% | |
75 Outperform | ¥67.90B | 12.98 | ― | 3.12% | 2.78% | -5.32% | |
70 Outperform | ¥35.10B | 10.46 | ― | 4.53% | -2.57% | 3.43% | |
70 Outperform | ¥79.68B | 10.57 | ― | 3.05% | 10.79% | 12.28% | |
64 Neutral | $154.35B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |